01/06
Headlines

NASDAQ:INSY

Active Watch List: INSYS Therapeutics (NASDAQ:INSY), Celladon Corporation (NASDAQ:CLDN), WisdomTree Investments, Inc. (NASDAQ:WETF), Arotech Corporation (NASDAQ:ARTX), DigitalGlobe, Inc. (NYSE:DGI)

Jason Knox03 mins

Insys Therapeutics, Inc. (NASDAQ:INSY) announced that the FDA has granted orphan drug status to its pharmaceutical cannabidiol (CBD), for the treatment of glioblastoma multiforme (GBM.V). Glioblastoma multiforme is the most common and aggressive form of malignant primary brain tumor. INSYS Therapeutics, Inc. (NASDAQ:INSY) belongs to Healthcare sector. Its net profit margin is 31.70% and weekly…

Read More

Investors Are Watching : Linear Technology (NASDAQ:LLTC), Technical Communications (NASDAQ:TCCO), Vaalco Energy (NYSE:EGY), INSYS Therapeutics (NASDAQ:INSY), Marrone Bio (NASDAQ:MBII)

Jason Knox03 mins

On 17 JULY Linear Technology Corporation (NASDAQ:LLTC) said that it is again eyeing Camas for a major expansion, and a decision could come later this summer. Linear Technology Corporation (NASDAQ:LLTC) belongs to Technology sector. Its net profit margin is 33.10% and weekly performance is -2.38%. On last trading day company shares ended up $44.25. Linear…

Read More

Investors Watch List : MER Telemanagement (NASDAQ:MTSL), CSP (NASDAQ:CSPI), PMC-Sierra (NASDAQ:PMCS), INSYS Therapeutics (NASDAQ:INSY), Cypress Semiconductor (NASDAQ:CY)

Colin Pettis02 mins

MER Telemanagement Solutions Ltd. (NASDAQ:MTSL) belongs to Technology sector. Its net profit margin is 7.30% and weekly performance is -2.80%. On last trading day company shares ended up $1.39. MER Telemanagement Solutions Ltd. (NASDAQ:MTSL) distance from 50-day simple moving average (SMA50) is -8.02%. CSP Inc. (NASDAQ:CSPI) , a provider of IT solutions, systems integration services and…

Read More

Biotech Insider Buying: Merrimack Pharmaceuticals (NASDAQ:MACK), Omeros (NASDAQ:OMER), Insys Therapeutics (NASDAQ:INSY), Agios Pharmaceuticals (NASDAQ:AGIO), BioTime (NYSEMKT:BTX)

Ryan Holtz03 mins

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Director Gary L. Crocker bought 36,000 shares of the stock in a transaction dated Monday, June 23rd. The shares were purchased at an average price of $6.84 per share, with a total value of $246,240.00. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) stock performance was 3.91% in last session and finished the day at…

Read More

Small Cap Insider Buying: Hercules Offshore (NASDAQ:HERO), Merrimack Pharmaceuticals (NASDAQ:MACK), Omeros Corporation (NASDAQ:OMER), Insys (NASDAQ:INSY), New Mountain Finance (NYSE:NMFC)

Kristen Barton03 mins

Hercules Offshore Inc (NASDAQ:HERO) Director Thomas R. Bates, Jr. purchased 20,000 shares of the stock on the open market in a transaction that occurred on Tuesday, June 24th. The stock was purchased at an average price of $3.93 per share, for a total transaction of $78,600.00. Following the completion of the transaction, the director now…

Read More

Biotech Insider Buying: OvaScience Inc (NASDAQ:OVAS), BioTime (NYSEMKT:BTX), Insys Therapeutics (NASDAQ:INSY), Novavax (NASDAQ:NVAX), ImmuCell Corporation (NASDAQ:ICCC)

Jason Knox03 mins

Ovascience Inc (NASDAQ:OVAS) major shareholder Fund L.P. Longwood bought 100,000 shares of the company’s stock on the open market in a transaction dated Friday, March 7th. The stock was purchased at an average cost of $10.00 per share, for a total transaction of $1,000,000.00. OvaScience Inc (NASDAQ:OVAS) stock performance was -2.98% in last session and…

Read More